131 related articles for article (PubMed ID: 11032625)
1. Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease.
Sáez-Valero J; Barquero MS; Marcos A; McLean CA; Small DH
J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):664-7. PubMed ID: 11032625
[TBL] [Abstract][Full Text] [Related]
2. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.
Sáez-Valero J; Sberna G; McLean CA; Small DH
J Neurochem; 1999 Apr; 72(4):1600-8. PubMed ID: 10098867
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
Appleyard ME; McDonald B
J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.
Sáez-Valero J; Fodero LR; Sjögren M; Andreasen N; Amici S; Gallai V; Vanderstichele H; Vanmechelen E; Parnetti L; Blennow K; Small DH
J Neurosci Res; 2003 May; 72(4):520-6. PubMed ID: 12704813
[TBL] [Abstract][Full Text] [Related]
5. An unusually glycosylated form of acetylcholinesterase is a CSF biomarker for Alzheimer's disease.
Sáez-Valero J; Mok SS; Small DH
Acta Neurol Scand Suppl; 2000; 176():49-52. PubMed ID: 11261805
[TBL] [Abstract][Full Text] [Related]
6. Association between acetylcholinesterase and beta-amyloid peptide in Alzheimer's cerebrospinal fluid.
García-Ayllón MS; Silveyra MX; Sáez-Valero J
Chem Biol Interact; 2008 Sep; 175(1-3):209-15. PubMed ID: 18554581
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase and butyrylcholinesterase glycoforms are biomarkers of Alzheimer's disease.
Sáez-Valero J; Small DH
J Alzheimers Dis; 2001 Jun; 3(3):323-328. PubMed ID: 12214053
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type.
Tune L; Gucker S; Folstein M; Oshida L; Coyle JT
Ann Neurol; 1985 Jan; 17(1):46-8. PubMed ID: 3985585
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Appleyard ME; Smith AD; Berman P; Wilcock GK; Esiri MM; Neary D; Bowen DM
Brain; 1987 Oct; 110 ( Pt 5)():1309-22. PubMed ID: 3676702
[TBL] [Abstract][Full Text] [Related]
10. Altered glycosylation of acetylcholinesterase in Creutzfeldt-Jakob disease.
Silveyra MX; Cuadrado-Corrales N; Marcos A; Barquero MS; Rábano A; Calero M; Sáez-Valero J
J Neurochem; 2006 Jan; 96(1):97-104. PubMed ID: 16277609
[TBL] [Abstract][Full Text] [Related]
11. Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease.
Sáez-Valero J; Small DH
Brain Res; 2001 Jan; 889(1-2):247-50. PubMed ID: 11166713
[TBL] [Abstract][Full Text] [Related]
12. Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's disease.
Navaratnam DS; Priddle JD; McDonald B; Esiri MM; Robinson JR; Smith AD
Lancet; 1991 Feb; 337(8739):447-50. PubMed ID: 1671469
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia.
Nakano S; Kato T; Nakamura S; Kameyama M
J Neurol Sci; 1986 Sep; 75(2):213-23. PubMed ID: 3760912
[TBL] [Abstract][Full Text] [Related]
14. Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition.
Fodero LR; Sáez-Valero J; McLean CA; Martins RN; Beyreuther K; Masters CL; Robertson TA; Small DH
J Neurochem; 2002 May; 81(3):441-8. PubMed ID: 12065653
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study.
Zubenko GS; Marquis JK; Volicer L; Direnfeld LK; Langlais PJ; Nixon RA
Biol Psychiatry; 1986 Dec; 21(14):1365-81. PubMed ID: 3024746
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normals.
Deutsch SI; Mohs RC; Levy MI; Rothpearl AB; Stockton D; Horvath T; Coco A; Davis KL
Biol Psychiatry; 1983 Dec; 18(12):1363-73. PubMed ID: 6661467
[TBL] [Abstract][Full Text] [Related]
17. Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease.
Elble R; Giacobini E; Scarsella GF
Arch Neurol; 1987 Apr; 44(4):403-7. PubMed ID: 3827696
[TBL] [Abstract][Full Text] [Related]
18. Activities and kinetic properties of lumbar cerebrospinal fluid cholinesterases in relation to clinical diagnosis, severity, and progression of Alzheimer's disease.
Huff FJ; Reiter CT; Protetch J
Can J Neurol Sci; 1989 Nov; 16(4):406-10. PubMed ID: 2804802
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease.
García-Ayllón MS; Silveyra MX; Andreasen N; Brimijoin S; Blennow K; Sáez-Valero J
J Neurochem; 2007 Jun; 101(6):1701-11. PubMed ID: 17326766
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid choline, and acetylcholinesterase activity in familial vs. non-familial Alzheimer's disease patients.
Kumar V; Giacobini E
Arch Gerontol Geriatr; 1988 Jun; 7(2):111-7. PubMed ID: 3415394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
